A study of drug-drug interactions in cancer patients of a south Indian tertiary care teaching hospital

Journal of Postgraduate Medicine

Volumn 57, Issue 3, 2011, Pages 206-210

  Kannan, G ^a   Anitha, R ^a   Rani, Vanitha ^a   Thennarasu, P ^a   Alosh, J ^a   Vasantha, J ^a   Martin, J R ^a   Uma, M R C ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Cancer chemotherapy; Drug interactions; Oncology

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; FOLINATE CALCIUM; METHOTREXATE; METRONIDAZOLE; ONDANSETRON; ONDANSTERON; PACLITAXEL; PARACETAMOL; PHENIRAMINE MALEATE; PIPERACILLIN; PREDNISOLONE; UNCLASSIFIED DRUG; VANCOMYCIN; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER PATIENT; DRUG SAFETY; DRUG SCREENING; FEMALE; GASTROINTESTINAL TOXICITY; HOSPITAL ADMISSION; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ONCOLOGY; PRESCRIPTION; PROSPECTIVE STUDY; TEACHING HOSPITAL; TERTIARY HEALTH CARE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DRUG INTERACTIONS; DRUG TOXICITY; FEMALE; HOSPITALS, TEACHING; HUMANS; INCIDENCE; INDIA; MALE; MEDICATION ERRORS; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80054035908     PISSN: 00223859     EISSN: 09722823     Source Type: Journal    
DOI: 10.4103/0022-3859.85207     Document Type: Article

References (19)

1. Kuhlman J, Muck W. Clinical-pharmacological strategies to assess drug interaction potential during drug development. Drug Saf 2001;24:715-25. (Pubitemid 32848351)
2. Singh BN, Malhotra BK. Effects of food on the clinical pharmacokinetics of anticancer agents: Underlying mechanisms and implications for oral chemotherapy. Clin Pharmacokinetic 2004;43:1127-56. (Pubitemid 40013180)
3. Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: Potential adverse interactions with anticancer agents. J Clin Oncol 2004;22:2489-503. (Pubitemid 41115408)
4. Ando Y. Drug interactions in cancer therapy. In: Figg WD, McLeod HL, editors. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Totowa, USA: Humana Press; 2004. pp. 215-30.
5. Buajordet I, Ebbesen J, Erikssen J, Brors O, Hilberg T. Fatal adverse drug events: The paradox of drug treatment. J Intern Med 2001;250:327-41. (Pubitemid 32955618)
6. Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug- disease interactions in the ED: Analysis of a high-risk population. Am J Emerg Med 2001;14:447-50.
7. Delafuente JC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 2003;48:133-43. (Pubitemid 37357294)
8. Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care 2003;21:153-8. (Pubitemid 37174004)
9. Evans WE, McLeod HL. Pharmacogenomics - drug disposition, drug targets, and side effects. N Engl J Med 2003;348:538-49. (Pubitemid 36159890)
10. Bernard SA, Bruera E. Drug interactions in palliative care. J Clin Oncol 2000;18:1780-99. (Pubitemid 30220558)
11. Riechelmann RP, Tannock IF, Wang L, Saad ED, Taback NA, Krzyzanowska MK. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst 2007;99:592-80.
12. Barrons R. Evaluation of personal digital assistant software for drug interactions. Am J Health Syst Pharm 2004;61:80-5.
13. De Jonge ME, Huitema AD, Rodenhuis S, Beijnen JH. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 2005;44:1135-64. (Pubitemid 41483700)
14. Baker AF, Dorr RT. Drug interactions with the taxanes: Clinical implications. Cancer Treat Rev 2001;27:221-33. (Pubitemid 32861409)
15. Geppert U, Beindl W, Hawranek T, Hintner H. Drug interactions in Clinical practice. A pilot project for quality assurance in prescribing. Hautarzt 2003;54:53-7. (Pubitemid 36752800)
16. McLeod HL. Therapeutic drug monitoring oppurtunities in cancer therapy. Pharmacol Ther 1997;74:39-54. (Pubitemid 27337353)
17. Machover D. A comprehensive review of 5-flurouracil and leucovorin in patients with metastatic colorectal carcinoma.Cancer 1997;80:1179-87.
18. Herr RD, Caravati EM, Tyler LS, Iorg E, Linscott MS. Prospective evaluation of adverse drug interactions in the emergency department. Ann Emerg Med 2007:21:1331-6.
19. Beers MH, Storrie M, Lee G. Potential adverse drug interactions in the emergency room. An issue in the quality of care. Ann Intern Med 1990;112:61-4. (Pubitemid 20026369)